Targeted Dual-Modal PET/SPECT-NIR Imaging: From Building Blocks and Construction Strategies to Applications.
Syed Muhammad UsamaSierra C MarkerServando Hernandez VargasSolmaz AghaAmiriSukhen C GhoshNaruhiko IkomaHop S Tran CaoMartin J SchnermannAli AzhdariniaPublished in: Cancers (2022)
Molecular imaging is an emerging non-invasive method to qualitatively and quantitively visualize and characterize biological processes. Among the imaging modalities, PET/SPECT and near-infrared (NIR) imaging provide synergistic properties that result in deep tissue penetration and up to cell-level resolution. Dual-modal PET/SPECT-NIR agents are commonly combined with a targeting ligand (e.g., antibody or small molecule) to engage biomolecules overexpressed in cancer, thereby enabling selective multimodal visualization of primary and metastatic tumors. The use of such agents for (i) preoperative patient selection and surgical planning and (ii) intraoperative FGS could improve surgical workflow and patient outcomes. However, the development of targeted dual-modal agents is a chemical challenge and a topic of ongoing research. In this review, we define key design considerations of targeted dual-modal imaging from a topological perspective, list targeted dual-modal probes disclosed in the last decade, review recent progress in the field of NIR fluorescent probe development, and highlight future directions in this rapidly developing field.
Keyphrases
- fluorescent probe
- cancer therapy
- fluorescence imaging
- pet ct
- small molecule
- high resolution
- living cells
- photodynamic therapy
- computed tomography
- positron emission tomography
- small cell lung cancer
- squamous cell carcinoma
- drug release
- patients undergoing
- single cell
- mass spectrometry
- mesenchymal stem cells
- case report
- young adults